Medical school application and matriculation rates decreased for underrepresented racial and ethnic minorities in medicine ...

Under the second Trump administration, CMMI has published far more detail about peformance of Enhancing Oncology Model ...

Multiple surgeries for glaucoma increased the risk of corneal edema in these patients, making lower-risk treatment ...

Chronic urticaria patients may have a higher risk of metabolic syndrome, with a pooled prevalence of 25.2% and an odds ratio ...

The FDA has approved an updated COVID-19 booster while limiting access to high-risk individuals, amid ongoing debates on ...

Many patients later diagnosed with high-grade serous cancer had prior surgical or genetic testing opportunities that could ...

Metabolic syndrome severity is a meaningful marker of chronic kidney disease risk even when patients do not have other major ...

Despite the findings, existing data around cardiovascular risk in chronic lymphocytic leukemia (CLL) are limited, and more ...

Ravi Vij, MD, MBA, discusses how measurable residual disease (MRD) testing is shaping treatment decisions in hematology and its potential to reduce costs and toxicity.

Patients with acute respiratory failure who’ve been placed on a mechanical ventilator are less likely to be transferred to high-volume centers if they are uninsured, thus increasing their odds of ...

In the final clip, James D. Chalmers, MBChB, PhD, notes that while the FDA approval of brensocatib is a milestone, questions remain on optimal patient selection, long-term benefits, and further ...

The FDA has broadened the indication for evolocumab (Repatha; Amgen) to include adults at increased risk of major adverse ...